Related Articles
Antitumor effects of IDN5109 on head and neck squamous cell carcinoma
Antitumor effects of lapatinib (GW572016), a dual inhibitor of EGFR and HER-2, in combination with cisplatin or paclitaxel on head and neck squamous cell carcinoma
Silencing of FANCD2 enhances the radiosensitivity of metastatic cervical lymph node-derived head and neck squamous cell carcinoma HSC-4 cells
Additive antitumor effects of celecoxib and simvastatin on head and neck squamous cell carcinoma in vitro
Head and neck cancers, but not benign lesions, express interleukin-4 receptors in situ.